RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Service Contact Center

Contact details for order support and technical support.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

Service Contact Center

Contact details for order support and technical support.

Learning Hub

Explore resources, including product documentation, software, webinars, videos, virtual demos and more.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

Quality & Safety Data

Find quality and safety documentation for your products.

Product & Technical Support

Find out which products work together, search our FAQ database and troubleshoot.

Ordering from QIAGEN

Learn about easy ordering options that offer fast and reliable delivery.

Shareholder Structure

Home  >  Investor Relations  >  Stock Information  >  Shareholder Structure

QIAGEN attaches great value to close contacts with its shareholders. On March 15, 2021, QIAGEN submitted a request for shareholder identification in accordance with section 49b of the Dutch Giro Securities Act (Wet giraal effectenverkeer), with a reference date of March 12, 2021. The requested information must be received by QIAGEN by March 18, 2021, at the latest. A shareholder who, alone or together with other shareholders, represents at least one/hundredth of QIAGEN's issued share capital, or is entitled to QIAGEN shares with an aggregate amount of EUR 250,000 on the reference date March 12, 2021, may submit a written request for information obtained via the shareholder identification to QIAGEN.

Name Holdings % Stake
BlackRock, Inc. 34,762,894 15.06
Sun Life Financial, Inc. (MFS) 12,998,483 5.63
Davidson Kempner Capital Management LP 9,609,709 4.16
State Street Corp. 7,628,807 3.30
Goldman Sachs & Co. LLC 7,063,376 3.06
The Vanguard Group, Inc. 6,955,512 3.01

Status: February 26, 2021

Source: QIAGEN Shareholder ID
Source: QIAGEN Shareholder ID